Randomized clinical trial· 2021

Effect of vasoactive intestinal polypeptide on development of migraine headaches: a randomized clinical trial

Pellesi L|Al-Karagholi MAM|Chaudhry BA|Snellman J|Hannibal J|Amin FM|Ashina M

JAMA Network Open

PubMed
34357396
Evidence level
strong
Verification
verified

Summary

A randomized infusion study evaluated whether prolonged VIP exposure provokes migraine attacks.

Limitations

Provocation model|Small specialist sample|Not a therapeutic efficacy trial

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.